Skip to main content

Inhibitex, Inc. Takeover Under Investor Investigation Over Potential Breaches Of Fiduciary Duties

  • If you purchased shares of Inhibitex, Inc. (NASDAQ: INHX) prior to January 7, 2012 and currently hold your NASDAQ:INHX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

San Diego, Jan. 07, 2012 (Shareholders Foundation) -- The announcement by Inhibitex, Inc. that it agreed to be acquired by Bristol-Myers Squibb for $26.00 per NASDAQ:INHX share prompted an investigation for investors in Inhibitex (INHX) shares concerning whether the offer to acquire Inhibitex and the buyout process are unfair to investors in NASDAQ: INHX shares and whether certain off...



You must register (for free) or login to view the entire investigation.